Wednesday, September 21, 2022 5:21:55 PM
AITX/RAD CEO Steve Reinharz, please do not forget to contact the United States Securities Exchange Commission stating you are going to have the 17,116,894 Restricted shares cancelled per your 9/20/2022 tweet. Steve are you intentionally mislead the public with your statement about the 17,116,894 restricted shares regarding the Transfer Agent's response to you? Their to you response clearly states that you have to request cancellation of those restricted shares. Did you communicate this differently to the public?
$AITX Some good news... Many shares that won't ever hit the market 👍👍👍 pic.twitter.com/1FYo2ThhIa
— Steve Reinharz (@SteveReinharz) September 20, 2022
Steve, there is not a United Securities Exchange Commission filing from you so far to cancel those 17,116,894 restricted shares.
https://www.otcmarkets.com/stock/AITX/disclosure - ZERO Proof as of 9/21/2022
Since you stated in your twitter post that shares wouldn't be hitting the Market, it's safe to say that you keep your word and not sell those shares....correct?? Steve when are you expects to complete the Transfer Agents Cancellation Resolution document and send it back to them to start the restricted shares cancellation process. When can the public anticipates this being done?
We also await more actual proof via an United States Security Exchange Commission stating those 17,116,894 restricted shares will be canceled with your name on it???
Given all the statements you have made regarding sales and backlogs IMO there shouldn't be a reason to sell those restricted shares...correct?
https://www.marketwatch.com/press-release/aitxs-subsidiary-robotic-assistance-devices-concludes-gsx-2022-with-pre-orders-for-30-rio-portable-solar-powered-security-towers-2022-09-15?mod=mw_quote_news_seemore
https://www.marketwatch.com/press-release/aitxs-subsidiary-robotic-assistance-devices-closes-fiscal-quarter-with-a-surge-of-sales-activity-2022-09-02?mod=mw_quote_news_seemore
https://www.marketwatch.com/press-release/aitxs-subsidiary-robotic-assistance-devices-receives-large-order-from-hospital-group-2022-08-31?mod=mw_quote_news_seemore
Recent AITX News
- Shares of this Innovative AI Solutions Firm Rip on Updated Pricing • AllPennyStocks.com • 05/06/2024 06:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 10:10:24 AM
- Shares Moving Up For AI SAAS Firm on News of an Initial Order • AllPennyStocks.com • 04/11/2024 03:47:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 11:04:41 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 11:08:07 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2024 11:01:50 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 11:09:08 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 11:07:07 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2024 11:03:17 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 11:03:17 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2024 11:05:06 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/08/2024 11:02:46 AM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/07/2024 05:15:21 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2024 11:05:50 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 11:02:25 AM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 01/30/2024 09:21:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 11:03:58 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 11:01:53 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 01/19/2024 09:00:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/17/2024 11:04:22 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/16/2024 08:59:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/09/2024 11:05:51 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2024 11:02:41 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/21/2023 11:03:03 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM